EGR2 Gene CMT4E Genetic Test
Components: EGR2 Gene CMT4E Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for EGR2 Gene CMT4E NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EGR2 Gene CMT4E.
Test Details: The EGR2 gene is associated with a type of Charcot-Marie-Tooth disease called CMT4E. CMT4E is a rare, inherited neurological disorder that affects the peripheral nerves and causes muscle weakness and wasting, as well as sensory loss in the limbs. NGS (next-generation sequencing) genetic testing is a type of genetic test that uses advanced technology to analyze multiple genes simultaneously. This allows for faster and more comprehensive analysis of genetic mutations associated with CMT4E. NGS genetic testing for CMT4E involves sequencing the entire EGR2 gene to identify any mutations or variations that may be causing the disease. This information can be used to make an accurate diagnosis, provide genetic counseling, and guide treatment options. Overall, NGS genetic testing for CMT4E can help individuals and families affected by this rare disease to better understand its underlying genetic causes and potentially improve their quality of life through early detection and management of symptoms.
Test Name | EGR2 Gene CMT4E Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for EGR2 Gene CMT4E NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with EGR2 Gene CMT4E |
Test Details |
The EGR2 gene is associated with a type of Charcot-Marie-Tooth disease called CMT4E. CMT4E is a rare, inherited neurological disorder that affects the peripheral nerves and causes muscle weakness and wasting, as well as sensory loss in the limbs. NGS (next-generation sequencing) genetic testing is a type of genetic test that uses advanced technology to analyze multiple genes simultaneously. This allows for faster and more comprehensive analysis of genetic mutations associated with CMT4E. NGS genetic testing for CMT4E involves sequencing the entire EGR2 gene to identify any mutations or variations that may be causing the disease. This information can be used to make an accurate diagnosis, provide genetic counseling, and guide treatment options. Overall, NGS genetic testing for CMT4E can help individuals and families affected by this rare disease to better understand its underlying genetic causes and potentially improve their quality of life through early detection and management of symptoms. |